WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock Ownership - Who owns Centessa Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Centessa Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Karen M. AndersonChief People Officer2026-03-2641,076$30.12
$1.24MSell
Gregory M. WeinhoffChief Business Officer2026-03-2623,998$3.85
$92.39kBuy
Gregory M. WeinhoffChief Business Officer2026-03-2623,998$30.00
$719.94kSell
Karen M. AndersonChief People Officer2026-03-2641,076$8.01
$329.02kBuy
Karen M. AndersonChief People Officer2026-03-1710,043$28.10
$282.21kSell
Karen M. AndersonChief People Officer2026-03-1710,043$4.01
$40.27kBuy
Karen M. AndersonChief People Officer2026-03-1664,768$28.21
$1.83MSell
Karen M. AndersonChief People Officer2026-03-1664,768$4.01
$259.72kBuy
Karen M. AndersonChief People Officer2026-03-13109,398$4.01
$438.69kBuy
Karen M. AndersonChief People Officer2026-03-1312,068$27.13
$327.44kSell

1 of 10

CNTA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CNTA insiders and whales buy or sell their stock.

CNTA Shareholders

What type of owners hold Centessa Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Medicxi Ventures Management Jersey Ltd12.92%19,963,157$788.15MInstitution
Avoro Capital Advisors LLC9.42%14,555,555$574.65MInstitution
Adage Capital Partners GP LLC7.30%11,281,741$445.40MInstitution
Index Venture Life Associates VI Ltd6.44%9,961,789$393.29MInstitution
Gap Bermuda Ltd6.26%9,681,818$382.24MInsider
Fmr LLC5.80%8,961,939$353.82MInstitution
General Atlantic LP3.96%6,117,715$241.53MInstitution
Farallon Capital Management LLC3.48%5,377,068$212.29MInstitution
Tcg Crossover Management LLC2.77%4,286,480$169.23MInstitution
Janus Henderson Group PLC2.65%4,093,608$161.62MInstitution

1 of 3

CNTA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CNTA91.12%8.88%Net BuyingNet Selling
TERN85.84%14.16%Net SellingNet Selling
APGE94.89%5.11%Net SellingNet Selling
COGT92.60%7.40%Net SellingNet Selling
PTGX82.89%17.11%Net SellingNet Selling
View Top Biotech Stocks

Centessa Pharmaceuticals Stock Ownership FAQ

Who owns Centessa Pharmaceuticals?

Centessa Pharmaceuticals (NASDAQ: CNTA) is owned by 93.01% institutional shareholders, 9.06% Centessa Pharmaceuticals insiders, and 0.00% retail investors. Gap Bermuda Ltd is the largest individual Centessa Pharmaceuticals shareholder, owning 9.68M shares representing 6.26% of the company. Gap Bermuda Ltd's Centessa Pharmaceuticals shares are currently valued at $382.24M.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.